Valion Bio (VBIO) EBT Margin Growth (3y) (2024 - 2026)
Valion Bio (VBIO) EBT Margin Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | 6,685.00 |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | -2,054.00 |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 8,006.00 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 9,980.00 |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | -9,922.00 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 31,363.00 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | -5,319.00 |
| 10 | Valion Bio | 414,049.64 | -1.79 Mn | -45,000.00 | 120,449.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.87 Mn |
| Dec 31, 2025 | 65,669.00 |
| Sep 30, 2025 | -114,574.00 |
| Jun 30, 2025 | -166,778.00 |
| Mar 31, 2025 | -155,306.00 |
| Dec 31, 2024 | -24,969.00 |
| Sep 30, 2024 | -69,203.00 |
| Jun 30, 2024 | -47,028.00 |
| Mar 31, 2024 | -3,887.00 |